CClinicalTrials.gg
RecruitingNCT07172568EPIC-BFRUpdated Sep 15, 2025

Blood Flow Restriction Training For The Treatment Of Lateral Epicondylopathy

An interventional study of Blood Flow Restriction and sham-Blood Flow Restriction in Elbow Tendinopathy, Elbow, Tennis and Lateral Epicondylitis, sponsored by Technical University of Munich. Recruiting at 1 site in Germany. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-09-15.

Sponsored by Technical University of Munich · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The study aims to evaluate the effectiveness of Blood Flow Restriction Training for the treatment of lateral elbow epicondylopathy.

Read the detailed description
  1. To test a non-invasive, rapid treatment option for epicondylopathia humeri radialis for its effectiveness, Blood Flow Restriction (BFR) training will be supplemented to the applied exercise therapy. In BFR training, blood flow to the muscle is reduced by tying off the limb to be trained, e.g. with a blood pressure cuff, to achieve mechanical compression of the underlying blood vessels. This results in increased accumulation of blood in the capillary bed distal to the pressure cuff. Although isolated adverse effects have been reported, based on the current literature, it can be assumed that BFR training is comparable to conventional training in terms of safety for the user. Regarding the effect of BFR applications, it has been shown that even BFR without additional training measures can reduce muscle atrophy occurring during immobilization. A systematic literature review confirmed the positive effect of BFR augmented strength training in terms of strength development as well as muscle gain. The first positive results of BFR training compared to conventional physiotherapy have already been shown in rehabilitation after replacement surgery of the anterior cruciate ligament and after treatment of a radius fracture. Therefore, there is a scientific interest to verify the effectivity of this method in another disease of the musculoskeletal system, epicondylopathia humeri radialis.

    Question: Does the implementation of a BFR-protocol in the physiotherapeutic treatment of epicondylopathia humeri radialis lead to a significantly pain relief and function improvement in the affected hand? Hypothesis: The implementation of a BFR-protocol in the physiotherapeutic treatment leads to a significantly pain relief an function improvement in comparison to a cohort without BFR.

  2. All patients who meet the inclusion criteria will be informed about the study in the special consultation for shoulder and elbow diseases and asked whether they would like to participate and will receive a declaration of participation if they agree. Patients are informed in detail that participation is voluntary, and that non-participation will not result in any disadvantages for their treatment. Prior to the start of therapy, one of the above-mentioned study physicians will personally inform the patient about the risks and benefits of the study. After sufficient time for reflection, the corresponding declaration of participation is gone through with the patient, signed by both parties in case of consent and the patient receives a copy of it. After signing the participation form, an appointment will be made to start the six-week randomized physiotherapy (2x per week a 20min; group A: Physiotherapy + BFR while intermittently wearing the BFR cuff (Delfi Medical Innocation Inc., Vancouver, Canada) at 50% of arterial occlusion pressure analogous to previous studies; Group B Physiotherapy + sham-BFR (BFR cuff inflated to 20mmHg). Patients are informed that they can discontinue therapy without giving a reason.

Physiotherapy treatment will be performed according to the current evidence-based protocol in the Department and Polyclinic for Sports Orthopedics of the Klinikum rechts der Isar of the Technical University of Munich twice a week over a period of six weeks. Randomization will be done by the treating physiotherapist(s) before the first physiotherapy session. Before the start of the first therapy unit (T1), as well as after completion of the six-week intervention (T2), six weeks after completion of therapy (T3) and again 12 weeks aufter completion of the physiotherapeutic treatment (T4), both clinical examinations to assess the progress of therapy by a blinded study physician and the completion of a standardized questionnaire by the subject will take place. No travel or expense allowance is provided. During the clinical examination, the joint status as well as the clinical signs of epicondylopathia radialis humeri will be collected. Further data collection is performed by means of questionnaires.

02

Conditions studied

  • Elbow Tendinopathy
  • Elbow, Tennis
  • Lateral Epicondylitis
  • Epicondylitis of the Elbow
  • Blood Flow Restriction Therapy
  • BFR

Keywords

  • Randomised controlled Trial
  • RCT
  • Interventional study
  • BFR
  • Blood-Flow-Restriction-Therapy
  • lateral Epicondylopathy
  • Epicondylitis
03

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • diagnosis of lateral epicondylitis
  • duration of symptoms > 6 weeks
  • failed physical therapy
  • absence of x-ray abnormalities
  • written and informed consent

Exclusion criteria

Exclusion Criteria:

  • prior joint infiltrations
  • duration of symptoms > 12 months
  • concomitant rheumatoid diseases
  • concomitant elbow pathologies, including medial epicondylitis
  • concomitant radicular symptoms of the cervical spine, shoulder or hand
  • traumatic etiology of symptoms
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    20mmHg pressure Blood Flow Restriction

    The patients in the control group are wearing a blood-flow-restriction cuff proximal to the elbow with an applied pressure of just 20mmHg. Studies have shown that this amount of pressure has no impact. The control group remains blind using the cuff with low pressure. The therapy protocol is exactly the same as in the Interventional group.

    Procedure: sham-Blood Flow Restriction

  • Experimental
    50% of Mean arterial blood pressure Blood Flow Restriction

    The patients in the intervention group are wearing a blood-flow-restriction cuff proximal to the elbow with an applied pressure of 50% of the mean arterial blood pressure. The therapy protocol is exactly the same as in the control group.

    Procedure: Blood Flow Restriction

Interventions

  • ProcedureBlood Flow Restriction

    In the intervention group, 50% of limb occlussion pressure are applied to the extremity during exercises.

  • Proceduresham-Blood Flow Restriction

    In the control group, 20 mmHg are applied to the extremity during exercises.

05

What researchers measure

Primary outcomes

  1. Visual Analog Scale for pain

    VAS at rest and at dorsal extension of the hand. Measuring the pain on a scale from 1-10. 1 means no pain and 10 means extreme pain. The investigators are measuring the pain on the VAS scale once before and three times after the intervention within a time frame of 3 Months (directly after the intervention, 6 weeks after the intervention and 12 Weeks after the intervention). A higher score means a worse outcome, a lower score means a better outcome.

    Time frame: 3 months

  2. Mayo Elbow Performance Score

    The Mayo Elbow Performance Score (MEPS) is a clinical tool used to assess the function of the elbow joint, particularly in patients with elbow disorders or after treatment (e.g., surgery). It evaluates pain, range of motion, function, and elbow stability. Range of Scores: 0 to 100. 100 represents excellent elbow function with no pain. 75-89 is considered good, 60-74 is fair, and below 60 is poor. Scores are assessed before and three times after the intervention: Immediately post-intervention. 6 weeks post-intervention. 12 weeks post-intervention. This allows tracking of elbow recovery and functional improvement over time. A higher score indicates better recovery and elbow function.

    Time frame: 3 Months

  3. Short-form 36 questionnaire (SF-36)

    It is a questionnaire which is answered by the patients. The SF-36 (Short Form 36) Health Survey is a widely used questionnaire designed to assess an individual's overall health status. It measures eight domains of health: Physical Functioning Role Physical Role Emotional Mental Health Vitality (Energy/Fatigue) Social Functioning Pain General Health Each domain is scored on a scale from 0 to 100, with 0 representing the worst health status and 100 representing the best. The scores are then used to evaluate physical and mental health, as well as the impact of health on daily functioning. Range of Scores: 0-100 for each domain. Higher scores represent better health and functioning. Lower scores indicate greater impairment or worse health status. It helps in understanding an individual's quality of life and the impact of disease or disability on their physical and mental well-being. It is commonly used to evaluate patient health outcomes.

    Time frame: 3 Months

  4. Disabilities of the Arm, Shoulder and Hand questionnaire

    The DASH (Disabilities of the Arm, Shoulder, and Hand) questionnaire is a tool used to assess the physical function and symptoms in patients with musculoskeletal disorders of the upper limb. It evaluates function and pain in daily activities. Range of Scores: 0 to 100. 0 represents no disability (full function, no pain). 100 represents maximum disability (severe limitation and pain). The DASH score is typically measured before and three times after an intervention: Immediately post-intervention. 6 weeks post-intervention. 12 weeks post-intervention. Lower scores indicate better function and less disability, while higher scores show greater functional impairment and pain. The DASH helps to monitor recovery and the effectiveness of treatments for upper limb conditions.

    Time frame: 3 Months

  5. Patient rated tennis elbow evaluation questionnaire

    The Patient-Rated Tennis Elbow Evaluation (PRTEE) is a questionnaire specifically designed to assess the severity of symptoms and the impact of lateral epicondylitis (tennis elbow) on a patient's daily life. It evaluates pain and function in the elbow, particularly in activities related to gripping and arm movement. Range of Scores: 0 to 100. 0 represents no pain or disability. 100 represents maximum pain or disability. The PRTEE is typically assessed before and three times after an intervention: Immediately post-intervention. 6 weeks post-intervention. 12 weeks post-intervention. Lower scores indicate less pain and disability, while higher scores suggest greater severity of symptoms. It is used to track the patient's progress and recovery from tennis elbow over time.

    Time frame: 3 Months

  6. clinical evaluation of the elbow

    clinical Evaluation including: Range of Motion

    Time frame: 3 Months

  7. Strength-Measurement: Dorsal extension of the hand

    Strength-Measurement: Dorsal extension of the hand using a dynamometer (MicroFET 2, Hoggan Scientific, Salt Lake City, USA). Measuring the affected elbow and the non-affected elbow

    Time frame: 3 Months

  8. Drop-Out

    statistical measurement of patients drop-out-quote using a Questionnaire about potential change to surgical Interventions or another type of therapy. statistical measurement of Lost to follow-up patients

    Time frame: 3 Months

  9. clinical examination of the elbow

    A clinical examination of the elbow is performed. The focus here is on the examination of possible instability in the elbow joint. To this end, valgus-axis stress is applied and the ability to open the joint is checked. The examination is assessed before and three times after an intervention: Foldability and instability indicate a poor outcome

    Time frame: 3 Months

  10. clinical evaluation of the elbow

    clinical evaluation of the elbow using Epicondylitis Tests (Cozen-Test)

    Time frame: 3 Months

  11. clinical evaluation of the elbow

    clinical evaluation of the elbow using Epicondylitis Tests (Reversed-Cozen-Test)

    Time frame: 3 Months

  12. clinical evaluation of the elbow

    clinical evaluation of the elbow using Epicondylitis Tests (Maudsley-Test)

    Time frame: 3 Months

  13. clinical examination of the elbow

    A clinical examination of the elbow is performed. The focus here is on the examination of possible instability in the elbow joint. To this end the milking maneuver is examined with possible medial opening. The examination is assessed before and three times after an intervention: Foldability and instability indicate a poor outcome

    Time frame: 3 Months

  14. clinical examination of the elbow

    A clinical examination of the elbow is performed. The focus here is on the examination of possible instability in the elbow joint. To this end the tweezer grip on the elbow are examined. The examination is assessed before and three times after an intervention: Foldability and instability indicate a poor outcome

    Time frame: 3 Months

  15. clinical examination of the elbow

    A clinical examination of the elbow is performed. The focus here is on the examination of possible instability in the elbow joint. To this end the pivot-shift test on the elbow is examined. The examination is assessed before and three times after an intervention: Foldability and instability indicate a poor outcome

    Time frame: 3 Months

  16. clinical examination of the elbow

    A clinical examination of the elbow is performed. The focus here is on the examination of possible instability in the elbow joint. To this end, varus-axis stress is applied and the ability to open the joint is checked. The examination is assessed before and three times after an intervention: Foldability and instability indicate a poor outcome

    Time frame: 3 months

Secondary outcomes

  1. Questionnaire

    The questionnaire the investigators created, also contains individual questions that ask about possible confounders. These are questions about gender * Age * Nicotine abuse * Type of sport, activity level/intensity, frequency with these questions the investigators would like to identify possible confounders.

    Time frame: 3 Months

  2. Body mass index (BMI)

    measuring secondary objective as a potential confounder

    Time frame: 3 Months

  3. Return-to-sports

    The Return to Sports Rate is a measure used to assess the percentage of individuals who return to their pre-injury or pre-intervention level of sports activity following treatment or rehabilitation. It provides insight into how effectively a patient has recovered and whether they can resume their sports participation at a similar level to before the injury. In this case, the investigators use a questionnaire to gather information about the type of sport, frequency, and weekly time commitment to sports activities. By comparing the responses from these time points, the investigators can calculate the Return to Sports Rate. This rate is determined by assessing how many participants have returned to their previous levels of sports activity, or how close they are to their baseline sports participation after the intervention.

    Time frame: 3 Months

  4. Return-to-work

    The Return to Work Rate is a measure used to assess the percentage of individuals who are able to return to their pre-injury or pre-intervention work activities following treatment or rehabilitation. It helps to evaluate the effectiveness of the intervention in enabling patients to resume their work duties. In this case, the investigators use a questionnaire to gather information about the type of work, work frequency, and the time commitment per week spent on work activities. By comparing the responses from these time points, the investigators can calculate the Return to Work Rate. This rate is determined by assessing how many participants have returned to their previous work activities or how close they are to their baseline work participation after the intervention.

    Time frame: 3 Months

06

Study locations

1 of 1 sites recruiting
  • Department of Sports Orthopaedics, Technical University of Munich
    Munich, Bavaria 81675, Germany
    Recruiting
07

References and documents

Publications

  • Hinz M, Franz A, Pirker C, Traimer S, Lappen S, Doucas A, Siebenlist S. [Blood flow restriction training as a treatment option for lateral elbow tendinopathy-a study presentation]. Orthopadie (Heidelb). 2023 May;52(5):365-370. doi: 10.1007/s00132-023-04370-w. Epub 2023 Apr 20. German. PubMed 37079041 ↗

Related links

Individual participant data

Plan to share: No — IPD is not shared due to strict data protection laws in Germany, such as the GDPR, which ensure the security of sensitive medical data. Sharing individual patient data poses significant risks to data security, particularly regarding unauthorized access or misuse. Additionally, explicit consent from participants is often missing for data sharing beyond the original research purpose. Without such consent, any disclosure would be legally impermissible and ethically problematic. Therefore, safeguarding privacy and complying with legal regulations are paramount.

08

Registry details

Key details

Study ID
NCT07172568
Lead sponsor
Technical University of Munich
Responsible party
Sponsor
First posted
Sep 15, 2025
Start date
Aug 25, 2021
Primary completion
Dec 31, 2025 (estimated)
Completion
Feb 2026 (estimated)
Last update
Sep 15, 2025

Study contacts

Alexandros Doucas, MD
Contact
a.doucas@tum.de
+491737442245
Pavel Kadantsev, MD
Contact
pavel.kadantsev@mri.tum.de
+4915221021120
Maximilian Hinz, MD
principal investigator · Department of Sports Orthopaedics, Technical University of Munich

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion